Clinical Dialogues: What Is the Role of Buprenorphine in Chronic Pain?

Sponsored by Endo Pharmaceuticals

This activity is not certified for credit.

Date
Tuesday, September 6

Start Time
12:30p

End Time
1:30p

Room
Castellana Ballroom
Level 3

Program Description
This program will discuss the current and emerging role of buprenorphine in the treatment of chronic pain. Following a brief discussion of the biochemical pharmacology of full and partial agonists, faculty will present results from studies supporting the recent approval of BELBUCA™, the first oral buccal formulation of buprenorphine for chronic pain. The program will feature a panel discussion on the efficacy, safety, and tolerability of BELBUCA™ in both opioid-naïve and opioid-experienced patients.

No Preregistration Required

Faculty
Jeffrey Fudin, BS, PharmD, FCCP
Jeffrey A. Gudin, MD
Richard Rauck, MD

Contact Name
Kristin Alfieri-Waldie

Contact Phone
(484) 216-6640

Contact email
Alfieri-Waldie.Kristin@endo.com

Related Content